CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Greenfern Industries Ltd is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Greenfern Industries Ltd
127 Normanby Road,, Normanby
AUCKLAND, TRA  4671  New Zealand Ticker: GFIGFI
Business Summary
Greenfern Industries Limited is a New Zealand-based medicinal cannabis and biotechnology company. The Company operates primarily from their medicinal cannabis research facility and hemp processing hub in Normanby, South Taranaki. The Company cultivates premium and consistent cannabis and through research and development, creates a pharmaceutical grade product range. The Company operates through two segments: Cannabis and therapeutics products, and Electricity generation. The Cannabis and therapeutics products segment reflects the activities of the arrangement with Cannvalate to manufacture and distribute white label products. The Electricity generation segment includes the generation and distribution of electricity. The Company operates through two geographical segments: New Zealand and Australia.

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
-Yes-----

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
9/30/20233/31/2023Yes----

Industries
SIC Code Description
2833 Medicinal chemicals and botanical products
0139 Field crops, except cash grains, not elsewhere classified
2844 Perfumes, cosmetics, and other toilet preparations
5122 Drugs, drug proprietaries, and druggists' sundries
4911 Electric services

Officers and Directors

Title
Name
Age		 Title
Date		 Start
Date
Non-Executive Independent Chairman of the Board MarvinYee 7/1/2023 10/1/2021
Co-Founder, Managing Director, Executive Director DanielCasey 6/29/2018
Co-Founder, Head Of Growth JohnHussey
6 additional Officers and Directors records available in full report.

General Information
Outstanding Shares: 109,857,152 (As of 9/30/2023)
Stock Exchange: NZE


Copyright © 2024 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Thursday, April 25, 2024